Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & ISI's SCI  
Users online: 2053  
Home | Subscribe | Feedback | Login 
About Latest Articles Back-Issues Articlesmenu-bullet Search Instructions Online Submission Subscribe Etcetera Contact
 
Read this article

 


    Article Cited by others

BRIEF REPORT

Extended interval between enzyme therapy infusions for adult patients with Gaucher's disease type 1.

Perez-Calvo J, Giraldo P, Pastores G M, Fernandez-Galan M, Marti­n-Nunez G, Pocovi M

Year : 2003| Volume: 49| Issue : 2 | Page no: 127-31

   This article has been cited by
 
1 In vitro correction of ARSA deficiency in human skin fibroblasts from Metachromatic Leukodystrophy patients after treatment with microencapsulated recombinant cells
Lagranha, V.L., Baldo, G., De Carvalho, T.G., Burin, M., Saraiva-Pereira, M.L., Matte, U., Giugliani, R.
Metabolic Brain Disease. 2008; 23(4): 469-484
[Pubmed]  [Google Scholar]
2 Therapy of adult Gaucher disease
Schmitz J, Poll LW, vom Dahl S
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. 2007; 92 (2): 148-152
[Pubmed]  [Google Scholar]
3 Low frequency maintenance therapy with imiglucerase in adult type I Gaucher disease: a prospective randomized controlled trial
de Fost M, Aerts JMFG, Groener JEM, et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. 2007; 92 (2): 215-221
[Pubmed]  [Google Scholar]
4 Metabolic correction in oligodendrocytes derived from metachromatic leukodystrophy mouse model by using encapsulated recombinant myoblasts
Consiglio A, Martino S, Dolcetta D, et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES. 2007; 255 (1-2): 7-16
[Pubmed]  [Google Scholar]
5 Short-term effect of miglustat in every day clinical use in treatment-naive or previously treated patients with type 1 Gauchers disease
Giraldo P, Latre P, Alfonso P, et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. 2006; 91 (5): 703-706
[Pubmed]  [Google Scholar]
6 Reduction of GAG storage in MPS II mouse model following implantation of encapsulated recombinant myoblasts
Friso A, Tomanin R, Alba S, et al.
JOURNAL OF GENE MEDICINE. 2005; 7 (11): 1482-1491
[Pubmed]  [Google Scholar]
7 Fabry disease: diagnosis and management, with emphasis on the renal manifestations
Warnock DG
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION. 2005; 14 (2): 87-95
[Pubmed]  [Google Scholar]
8 The need to define guidelines for maintenance enzyme replacement therapy for Gaucher disease: Expanded intervals, dose modification, or drug vacations?
Zimran, A., Elstein, D.
Journal of Postgraduate Medicine. 2003; 49(2): 130-131
[Pubmed]  [Google Scholar]

 

Online since 12th February '04
© 2004 - Journal of Postgraduate Medicine
Official Publication of the Staff Society of the Seth GS Medical College and KEM Hospital, Mumbai, India
Published by Wolters Kluwer - Medknow